SIMULPHARMA ApS: Financial statements 2023
CVR: 32832075
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 114,981 and a net result of DKK -57,341 compared with DKK -58,155 the year before. That is a decrease of 76.3% compared with the year before. The profit margin was -49.9%. Equity in the 2023 report amounted to DKK 22,477. The solvency ratio was 100%. The company had 1 employee in the financial year.
- Revenue
- DKK 114,981
- Gross Profit
- DKK 114,981
- Profit/Loss
- DKK -57,341
- Equity
- DKK 22,477
- Total Assets
- DKK 22,477
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 115K | 115K | -57K | 22K | 1 |
| 2022 | 484K | 406K | -58K | 80K | 1 |
| 2021 | 636K | 636K | -83K | 138K | 1 |
| 2020 | 719K | 719K | 36K | 221K | 1 |
| 2019 | 905K | -15K | -13K | 185K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
SIMULPHARMA ApS has published its annual report for 2022. Revenue came to DKK 484,388, and the net result was DKK -58,155.
About SIMULPHARMA ApS
SIMULPHARMA ApS was a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company has been dissolved on 24 August 2026. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company has 1 employee (2025). In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity in the 2024 report amounted to DKK 63,769.